Displaying drugs 1076 - 1100 of 1338 in total
Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester
Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. [PubChem]
Experimental
Glycinamide Ribonucleotide
Experimental
Aminophosphonic acid-guanylate ester
Experimental
Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose
Experimental
Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
Experimental
3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate
Experimental
Isopentyl Pyrophosphate
Experimental
Pentyl Trihydrogen Diphosphate
Experimental
N-(2-Aminoethyl)-1-aziridineethanamine
First described in the literature in 2004, N-(2-Aminoethyl)-1-aziridineethanamine is an experimental angiotensin converting enzyme 2 inhibitor investigated for its use in treating cardiovascular disease and its activity against Severe Acute Respiratory Syndrome (SARS).
Experimental
Matched Categories: … ACE Inhibitors and Calcium Channel Blockers …
Tryptophanyl-5'amp
Experimental
Palopegteriparatide
Palopegteriparatide is a mPEG conjugated parathyroid hormone 1-34.
Investigational
Matched Categories: … Calcium Homeostasis …
Histidyl-Adenosine Monophosphate
Experimental
Metrizamide
Metrizamide is a solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.
Experimental
UDP-6-sulfoquinovose
Experimental
Diguanosine-5'-Triphosphate
Experimental
(Diphosphono)Aminophosphonic Acid
Experimental
Triphosphoric acid
Used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative.
Experimental
Berbamine
Investigational
Matched Categories: … Calcium Channel Blockers ... Calcium-Regulating Hormones and Agents …
Canfosfamide
Canfosfamide is an active agent in chemotherapy-resistant ovarian cancer.
Investigational
CTT-1057
CTT-1057 is under investigation in clinical trial NCT03427476 (CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma).
Investigational
Eritoran
Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.
Investigational
6'-Methyl-Thiamin Diphosphate
Experimental
2'-O-Acetyl Adenosine-5-Diphosphoribose
Experimental
Flavin-adenine dinucleotide-N5-isobutyl ketone
Experimental
Displaying drugs 1076 - 1100 of 1338 in total